On June 27, Future Vision, a children’s ophthalmology brand, announced the completion of its Series B financing. This round of financing was led by Yuansheng Venture Capital, and the old shareholder Chengshu Investment followed.
Future Vision was founded in 2015 and is headquartered in Lujiazui, Pudong, Shanghai. Future Vision is an eye health chain service brand integrating ophthalmic clinic chain and eye care product R&D and sales. There are 12 ophthalmic chain institutions in Shanghai, providing standardized diagnosis and treatment service technology and equipment, and a team of ophthalmologists, professional optometrists and nurses. The business scope includes comprehensive eye examination, eye disease prevention and treatment, medical optometry, vision training, etc., focusing on the prevention and control of myopia, refractive error (myopia, hyperopia, astigmatism) correction, amblyopia training, and strabismus surgery for children and adolescents Before and after binocular vision function training, adult medical optometry, dry eye and other basic eye disease treatment services.
media coverage
Investment Community Yiou Investment China Network
Related events
- Future Vision, a leading brand of children’s ophthalmology, completed B round of financing2022-06-27
- Tupai Medical has received 200 million yuan in Series B financing and is deeply engaged in the field of high-end ophthalmic equipment2021-12-14
- “Vision Information” completed the B round of 100 million yuan financing2021-09-15
- Xi Ran Medical received tens of millions of RMB in angel round financing2021-08-06
- Ping An Good Doctor Internet Eye Center was established2020-11-10
This article is reprinted from: https://readhub.cn/topic/8hbh1xehIFs
This site is for inclusion only, and the copyright belongs to the original author.